Moderna, Inc.
MRNA NASDAQHealthcare ★★★★★Latest Earnings
Date
Jul 31, 2026
ET
EPS Est.
-2.03
EPS Actual
-1.97
Revenue Est.
$102.9M
Revenue Actual
$145M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-1.40
Revenue Est.
$872.9M
Company Overview
Moderna, Inc. (ticker MRNA) is listed on NASDAQ with a market cap of about $57.59B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of -1.40. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Jul 31, 2026
Feb 23, 2023Range: -9.53 ~ 3.61Jul 31, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 31, 2026 | -- | -2.03 | -1.97 | $102.9M | $145M |
| May 1, 2026 | -- | -4.45 | Above forecast↑-3.40 | $236.4M | $389M |
| Feb 13, 2026 | -- | -2.54 | Above forecast↑-2.11 | $635.2M | $678M |
| Nov 6, 2025 | -- | -1.87 | Above forecast↑-0.51 | $920.9M | $1.02B |
| Aug 1, 2025 | -- | -2.99 | Above forecast↑-2.13 | $893.3M | $142M |
| May 1, 2025 | -- | -2.92 | -2.52 | $116.7M | $107M |
| Feb 14, 2025 | -- | -2.68 | -2.50 | $942.8M | $956M |
| Nov 7, 2024 | -- | -1.91 | Above forecast↑0.03 | $1.25B | $1.86B |
| Aug 1, 2024 | -- | -3.35 | -3.33 | $128.4M | $241M |
| May 2, 2024 | -- | -3.56 | -3.07 | $93.3M | $167M |
| Feb 22, 2024 | -- | -0.97 | Above forecast↑0.55 | $2.51B | $2.81B |
| Nov 2, 2023 | -- | -1.93 | Below forecast↓-9.53 | $1.38B | $1.83B |
| Aug 3, 2023 | -- | -3.84 | -3.62 | $319.6M | $344M |
| May 4, 2023 | -- | -1.77 | Above forecast↑0.19 | $1.18B | $1.84B |
| Feb 23, 2023 | -- | 4.68 | Below forecast↓3.61 | $5.02B | $5.08B |
Original Filings (SEC)
10-Q2026-07-31 ↗
8-K2026-07-31 ↗
8-K2026-07-08 ↗
8-K2026-05-11 ↗
10-Q2026-05-01 ↗
8-K2026-03-05 ↗
10-K2026-02-20 ↗
8-K2026-02-13 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
